Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients presented for BPH surgery at our out patient clinic will be assessed for abnormal bleeding profile.
Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based on prostate size cut off point of 80ml Larger prostates will be treated with HoLEP Smaller prostates will be treated with greenlight PVP
Elderly patients with bleeding tendency either secondary;
Laser prostate surery was introduced to overcome this difficulty. However, till now there is no head to head comparision of different types of laser procedures in treating this subset of patients In the current study patients presented for BPH surgery in a tertiarry referral prostate unit will be assessed for bleeding tendency and will be treated either by Holmium laser enucleatiuon of the prostate or Greenlight laser vaporization of the prostate Single surgeon will perform all cases
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HoLEP | Active Comparator | Holmium laser enucleation of the prostate |
|
| Greenlight laser PVP | Active Comparator | Phtoselective vaporization of the prostate |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HoLEP | Procedure | Holmium laser enucleation of the prsotate |
| |
| Greenlight laser PVP |
| Measure | Description | Time Frame |
|---|---|---|
| perioperative blood loss | 48 hours |
| Measure | Description | Time Frame |
|---|---|---|
| readmission | 30 days | |
| blood transfusion | 30 days | |
| flow rate |
Not provided
Inclusion Criteria:
BPH patients candidate for transurethral prostate surgery after failure of medical treatment
Perioperative uncorrected Blleding tendency
patients with naturally induced uncorrectable bleeding tendency;
Patients on oral antiplatlet that deemed unsafe to stop prior to surgery as per intenist
Patients on oral anticoagulant that deemed unsafe to stop prior to surgery as per intenist
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ahmed m Elshal, MD | Contact | +20502262222 | 1428 | ELSHALAM@GMAIL.COM |
| Name | Affiliation | Role |
|---|---|---|
| Ahmed m Elshal, MD | Mansoura University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Urology and Nephrology Center | Recruiting | Al Mansurah | Aldakahlia | 35516 | Egypt |
Not provided
| ID | Term |
|---|---|
| D011470 | Prostatic Hyperplasia |
| ID | Term |
|---|---|
| D011469 | Prostatic Diseases |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Procedure |
Greenlight laser (532nm) Photoslective vaporization of the prostate |
|
| 3 months |
| D052801 |
| Male Urogenital Diseases |